<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832039</url>
  </required_header>
  <id_info>
    <org_study_id>EudraCT 2007-004333-42</org_study_id>
    <secondary_id>01 KI 01 06</secondary_id>
    <secondary_id>SE120301S</secondary_id>
    <nct_id>NCT00832039</nct_id>
  </id_info>
  <brief_title>Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis</brief_title>
  <acronym>SISPCT</acronym>
  <official_title>Prospective, Randomized Multicenter Trial of Adjunctive Intravenous Therapy With Sodium-selenite(Selenase®, Double-blinded) and a Procalcitonin Guided Causal Therapy (Open) of Severe Sepsis or Septic Shock.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kompetenznetz Sepsis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biosyn</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brahms AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kompetenznetz Sepsis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe sepsis and septic shock are diseases of infectious origin with a high risk of death.
      The purpose of this study is to determine whether the intravenous application of selenium
      (given as sodium-selenite) can reduce mortality in patients with severe sepsis or septic
      shock. Additionally, it is investigated, whether the measurement of procalcitonin - a marker
      of infection - can be used to guide anti-infectious measures in this disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter trial of the German Network Sepsis (SepNet) on patients with severe
      sepsis or septic shock. This study is supported by unrestricted grants.

      The release of reactive oxygen species is an important factor in the development of sepsis
      induced multiorgan dysfunction syndrome. Common protection mechanisms are impaired in this
      syndrome. Serum levels of selenium, a cofactor of the glutathionperoxidase, are reduced.
      Several studies suggest a benefit of selenium application in patients with severe sepsis but
      data from large clinical trials are not available. After inclusion into the study, patients
      are randomly allocated to a placebo or selenium group. Treating physicians and patients are
      blinded regarding the allocation. The selenium group receives sodium selenite intravenously -
      1000 µg as a bolus followed by a continuous infusion of 1000 µg per day until the end of ICU
      treatment but not longer than 21 days.

      Procalcitonin (PCT) is a biomarker which is elevated in the blood of patients with severe
      sepsis/septic shock. Data from patients with community acquired pneumonia demonstrated that
      this biomarker can be used to decide on the duration of antimicrobial therapy. Studies with
      small sample size seem to confirm this in ICU patients with severe sepsis. However, this
      needs to be confirmed in a larger cohort. All patients are randomly allocated to a PCT guided
      algorithm or a control group. In the PCT-guided group, PCT is measured at randomization, day
      4, 7, 10, and 14. Depending on the PCT course, the protocol recommends to change, alter, or
      stop anti-infectious measures. In the control group, anti-infectious therapy is left to the
      discretion of the treating physician.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean total SOFA and SOFA subscores</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency and duration of mechanical ventilation</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency and duration of vasopressor support</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of adverse events and severe adverse events</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical cure and microbiological cure</measure>
    <time_frame>days 4, 7, 10, 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of antimicrobial therapy</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of antimicrobial therapy</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to change of antibiotic therapy</measure>
    <time_frame>duration of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive without antimicrobial therapy</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of resistancies against antibiotics (VRE, MRSA, ESBL)</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of surgical procedures for focus control</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of procedures to diagnose infections</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of new infections</measure>
    <time_frame>study duration</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1089</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>SelPCT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient receives sodium-selenite; causal therapy is guided by a PCT based algorithm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SelKon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient receives sodium-selenite; causal therapy is not guided by a PCT based algorithm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PlacPCT</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient receives placebo; causal therapy is guided by a PCT based algorithm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PlacKon</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient receives placebo; causal therapy is not guided by a PCT based algorithm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium-selenite</intervention_name>
    <description>An intravenous bolus of 1000 µg followed by a continuous intravenous infusion of 1000 µg/day until patient is discharged from the ICU but not more than 21 applications à 24 hours.</description>
    <arm_group_label>SelPCT</arm_group_label>
    <arm_group_label>SelKon</arm_group_label>
    <other_name>selenase T</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>An intravenous bolus of placebo followed by a continuous intravenous infusion with placebo until patient is discharged from the ICU but not more than 21 applications à 24 hours.</description>
    <arm_group_label>PlacPCT</arm_group_label>
    <arm_group_label>PlacKon</arm_group_label>
    <other_name>0.9 % sodium chlorid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Procalcitonin guided therapy</intervention_name>
    <description>Causal therapy of sepsis is guided by applying the following algorithm:
Day 4: PCT drop from baseline &gt;=50%: no change in causal therapy; PCT drop from baseline &lt;50%: change or optimize antimicrobial therapy, new intervention (i.e. surgery, diagnostics) recommended for source control.
Day 7, 10, 14: PCT &lt;=1.0 ng/ml: finish antimicrobial therapy; PCT &gt;1.0 ng/ml and PCT drop from last PCT measurement &gt;=50%: finish antimicrobial therapy; PCT &gt;1.0 ng/ml and PCT drop from last PCT measurement &lt;50%: change or optimize antimicrobial therapy, new intervention (i.e. surgery, diagnostics) recommended for source control.</description>
    <arm_group_label>SelPCT</arm_group_label>
    <arm_group_label>PlacPCT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis or septic shock according to ACCP/SCCM criteria

          -  Onset of severe sepsis or septic shock &lt;24 h

          -  Age &gt;= 18 years

          -  Informed consent

        Exclusion Criteria:

          -  Pregnant or breast-feeding women

          -  Fertile female women without effective contraception

          -  Participation in interventional clinical trial within the last 30 days

          -  Current participation in any study

          -  Former participation in this trial

          -  Selenium intoxication

          -  No commitment to full patient support (i.e. DNR order)

          -  Patient's death is considered imminent due to coexisting disease

          -  Relationship of the patient to study team member (i.e. colleague, relative)

          -  Infection where guidelines recommend a longer duration of antimicrobial therapy (i.e.
             endocarditis, tuberculosis, malaria etc)

          -  Immunocompromised patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konrad Reinhart, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Jena; Dep. of Anesthesiology and Intensive Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Löffler</last_name>
    <role>Study Director</role>
    <affiliation>University Leipzig; Koordinierungszentrum für Klinische Studien Leipzig (KKSL)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Deufel, M. D.</last_name>
    <role>Study Director</role>
    <affiliation>University Hopitel Jena, Institute for Medical Chemistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen - Dep. of Intensive Care Medicine</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg - Dep. of Medicine I</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Hospital Berlin - Dep. of Anaesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln - Dep. of Anesthesiology, Intensive Care Medicine and Pain Therapy</name>
      <address>
        <city>Berlin</city>
        <zip>12313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK-Kliniken Berlin-Köpenick - Dep. of Anesthesiology, Pain Therapy, and Intensive Care Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>12559</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin - Campus Virchow-Klinikum - Dep. of Nephrology</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev. Krankenhaus Gilead - Dep. of Anesthesiology</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Bonn - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Dresden - Dep. of Anesthesiology and Intensive Care Med.</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Erfurt - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Erlangen-Nürnberg - Dep. of Medicine IV</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J.-W. Goethe University Hospital - Dep. of Anaesthesiology, Intensive Care Medicine and Pain Therapy</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Freiburg- Dep. of Surgery</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ernst-Moritz-Arndt-Universität Greifswald - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georg August Universität Göttingen - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin-Luther-Universität Halle-Wittenberg - Dep. of Anesthesiology</name>
      <address>
        <city>Halle</city>
        <zip>06097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Halle - Dep. of Medicine III</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf - Dep. of Intensive Care Medicine</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg - study center Anesthesiology/Surgery</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westküstenklinikum Heide - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Heide</city>
        <zip>25746</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Jena, Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Kiel - Dep. of. Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth-Krankenhaus - Dep. of Anesthesiology</name>
      <address>
        <city>Köln-Hohenlind</city>
        <zip>50935</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Köln - Dep. of Medicine I</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Leipzig - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Mannheim - Dep. of Medicine I</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Munich - Dep. of Internal Medicine</name>
      <address>
        <city>Munich</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Munich - Dep. of Anaesthesiology</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Munich Harlaching - Dep. of Internal Acute Medicine and Prevention</name>
      <address>
        <city>Munich</city>
        <zip>81545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus München-Neuperlach - Dep. of Anesthesiology</name>
      <address>
        <city>München</city>
        <zip>81737</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Münster - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg GmbH - Dep. of Anesthesiology</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.tmf-ev.de/EnglishSite/MemberNetworks.aspx</url>
    <description>Networks of competence in medicine (an initiative of the German government)</description>
  </link>
  <link>
    <url>http://www.sepsis-gesellschaft.de</url>
    <description>German Sepsis Society</description>
  </link>
  <link>
    <url>http://www.sepsis-gesellschaft.de/DSG/Deutsch/SepNet?sid=nbGlH39rI6b9u2fBVVhxiM&amp;iid=1</url>
    <description>Competence Network Sepsis (SepNet)</description>
  </link>
  <link>
    <url>http://www.survivingsepsis.org</url>
    <description>Surviving Sepsis Campaign</description>
  </link>
  <results_reference>
    <citation>Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Gründling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K; for SepNet Critical Care Trials Group. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. JAMA Intern Med. 2016 Sep 1;176(9):1266-76. doi: 10.1001/jamainternmed.2016.2514.</citation>
    <PMID>27428731</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2009</study_first_submitted>
  <study_first_submitted_qc>January 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2009</study_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>adjunctive therapy</keyword>
  <keyword>sodium-selenite</keyword>
  <keyword>procalcitonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Calcitonin</mesh_term>
    <mesh_term>Selenious Acid</mesh_term>
    <mesh_term>Sodium Selenite</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

